Skip to main content
Eric Nuermberger, MD, Infectious Disease, Baltimore, MD

EricLeeNuermbergerMD

Infectious Disease • Baltimore, MD

Associate Professor of Medicine, Johns Hopkins University School of Medicine

Join to view full profile

Dr. Nuermberger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Nuermberger's full profile

Already have an account?

  • Office

    1800 Orleans Street
    Baltimore, MD 21287
    Phone+1 410-955-5000
    Fax+1 410-955-5001

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityFellowship, Infectious Disease, 1999 - 2003
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1996 - 1999
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 1996

Certifications & Licensure

  • MD State Medical License
    MD State Medical License 2000 - 2025
  • FL State Medical License
    FL State Medical License 2015 - 2022
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Press Mentions

  • New Consortium Receives NIH Grant to Accelerate Development of Effective TB Treatments
    New Consortium Receives NIH Grant to Accelerate Development of Effective TB TreatmentsJuly 10th, 2024
  • Tip Sheet: Johns Hopkins Researchers Present at Annual CROI Meeting
    Tip Sheet: Johns Hopkins Researchers Present at Annual CROI MeetingMarch 1st, 2018
  • Africa: Cure at Last for Multi-Drug-Resistant TB
    Africa: Cure at Last for Multi-Drug-Resistant TBMarch 31st, 2017

Grant Support

  • Advancing New Drug Regimens For Mdr/Xdr TBNational Institute Of Allergy And Infectious Diseases2010–2011
  • Defining Moxifloxacin As A First-Line TB DrugNational Institute Of Allergy And Infectious Diseases2004–2008

External Links

Dr. Eric Nuermberger, Dr. Eric Nuermberger, MD, Dr. E Nuermberger, Dr. Eric Lee Nuermberger